EWSR1/FUS-NFATc2 rearranged round cell sarcoma: clinicopathological series of 4 cases and literature review

JA Diaz-Perez, GP Nielsen, C Antonescu, MS Taylor… - Human pathology, 2019 - Elsevier
The classification of bone neoplasms composed of small round cells is experiencing a
transformation after the discovery of various gene fusion rearrangements that determine …

CD99: a cell surface protein with an oncojanus role in tumors

MC Manara, M Pasello, K Scotlandi - Genes, 2018 - mdpi.com
The cell surface molecule CD99 has gained interest because of its involvement in regulating
cell differentiation and adhesion/migration of immune and tumor cells. However, the …

Genomics and therapeutic vulnerabilities of primary bone tumors

K Scotlandi, CM Hattinger, E Pellegrini, M Gambarotti… - Cells, 2020 - mdpi.com
Osteosarcoma, Ewing sarcoma and chondrosarcoma are rare diseases but the most
common primary tumors of bone. The genes directly involved in the sarcomagenesis, tumor …

Preclinical in vivo modeling of pediatric sarcoma—promises and limitations

R Imle, FKF Kommoss, A Banito - Journal of Clinical Medicine, 2021 - mdpi.com
Pediatric sarcomas are an extremely heterogeneous group of genetically distinct diseases.
Despite the increasing knowledge on their molecular makeup in recent years, true …

CD99 and polymeric immunoglobulin receptor peptides deregulation in critical COVID‐19: A potential link to molecular pathophysiology?

J Siwy, R Wendt, A Albalat, T He, H Mischak… - …, 2021 - Wiley Online Library
Identification of significant changes in urinary peptides may enable improved understanding
of molecular disease mechanisms. We aimed towards identifying urinary peptides …

Pharmacological targeting of P300/CBP reveals EWS:: FLI1-mediated senescence evasion in Ewing sarcoma

E Wei, A Mitanoska, Q O'Brien, K Porter, MK Molina… - Molecular Cancer, 2024 - Springer
Ewing sarcoma (ES) poses a significant therapeutic challenge due to the difficulty in
targeting its main oncodriver, EWS:: FLI1. We show that pharmacological targeting of the …

[HTML][HTML] GDF6-CD99 signaling regulates src and ewing sarcoma growth

F Zhou, DJ Elzi, P Jayabal, X Ma, YC Chiu, Y Chen… - Cell reports, 2020 - cell.com
We report here that the autocrine signaling mediated by growth and differentiation factor 6
(GDF6), a member of the bone morphogenetic protein (BMP) family of cytokines, maintains …

Signaling pathways and targeted therapies in Ewing sarcoma

K Jia, L Cao, Y Yu, D Jing, W Wu, BA Van Tine… - Pharmacology & …, 2024 - Elsevier
Ewing sarcoma, the second most prevalent malignant bone tumor with potential occurrence
in soft tissues, exhibits a high level of aggressiveness, primarily afflicting children and …

CD99 expression in glioblastoma molecular subtypes and role in migration and invasion

LC Cardoso, RS Soares, TS Laurentino… - International journal of …, 2019 - mdpi.com
Glioblastoma (GBM) is the most aggressive type of brain tumor, with an overall survival of 17
months under the current standard of care therapy. CD99, an over-expressed …

Gene expression profile association with poor prognosis in epithelial ovarian cancer patients

DVNP Oliveira, KP Prahm, IJ Christensen, A Hansen… - Scientific reports, 2021 - nature.com
Ovarian cancer (OC) is the eighth most common type of cancer for women worldwide. The
current diagnostic and prognostic routine available for OC management either lack …